Dyslipidemia is a protective factor in amyotrophic lateral sclerosis
Luc Dupuis(Université de Strasbourg), Vincent Meininger(Générale de Santé), Danielle Seilhean(Inserm), Anissa Fergani(Inserm), P. Corcia(Inserm), Randa Bittar(Inserm), Dominique Bonnefont‐Rousselot(Sorbonne Université), Lucette Lacomblez(Sorbonne Université), Jean-Philippe Loeffler(Inserm), J.‐J. Hauw(Inserm), José‐Luis González de Aguilar(Inserm)
Cited by 543
Related Papers
A Controlled Trial of Riluzole in Amyotrophic Lateral Sclerosis
|New England Journal of Medicine|1994|2.2k
TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis
|Nature Genetics|2008|1.5k
Dose-ranging study of riluzole in amyotrophic lateral sclerosis
|The Lancet|1996|1.3k